Elanco Animal Health Incorporated Financials

Market Capitalization $7.27 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	19.52
Forward PE	15.57
Price to Sales TTM	$1.64
Price to Book MRQ	$1.14
Enterprise to Revenue	2.49
Enterprise to EBITDA	12.76

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	8.43%
Operating Margin	10.14%
Return on Assets TTM	1.14%
Return on Equity TTM	6.01%

Income Statement

Revenue TTM	$4,426,999,808
Revenue per Share TTM	$8.95
Quarterly Revenue Growth	-1.00%
Gross Profit TTM	$2,430,000,128
EBITDA	$875,000,000
Net Income to Common TTM	$373,000,000
Diluted EPS TTM	$0.75
Quarterly Earnings Growth YoY	109.40%

Balance Sheet

Total Cash MRQ	$487,000,000
Total Cash per Share MRQ	$0.98
Total Debt MRQ	$
Total Debt to Equity MRQ	69.18
Current Ratio MRQ	2.71
Book Value per Share MRQ	$12.80

Cash Flow

Operating Cash Flow TTM	$535,000,000
Levered Free Cash Flow TTM	$1,319,500,032

ELAN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	494,445,839
Float Shares	492,857,091
Avg 10 Volume	5,036,680
Avg 30 Volume	None
Shares Short	24,284,022
Short Ratio	4.03
Short % of Shares	6.76%
% Held by Insiders	1.03%
% Held by Institutions	101.48%

Stock Price Summary

Beta	1.68
Fifty Two Week Low	$8.02
Fifty Two Week High	$15.78
Fifty Two Week Change	2.87%
Day 50 MA	$12.67
Day 200 MA	$12.21

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date